Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling

@article{Thomas2010EstrogenRB,
  title={Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling},
  author={C. Thomas and A. Strom and K. Lindberg and J. Gustafsson},
  journal={Breast Cancer Research and Treatment},
  year={2010},
  volume={127},
  pages={417-427}
}
  • C. Thomas, A. Strom, +1 author J. Gustafsson
  • Published 2010
  • Biology, Medicine
  • Breast Cancer Research and Treatment
    • Estrogen receptor beta (ERβ) inhibits proliferation in different cellular systems by regulating components of the cell cycle machinery. Eukaryotic cells respond to DNA damage by arresting in G1, S, or G2 phases of the cell cycle to initiate DNA repair. Most tumor cells due to disruptions in the p53-dependent G1 pathway are dependent on S-phase and G2/M checkpoints to maintain genomic integrity in response to DNA damage. We report that induction of ERβ expression causes abrogation of the S-phase… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    45 Citations
    Background Citations
    19
    Methods Citations
    2
    Results Citations
    7
    45 Citations
    Citation Type

    Citation Type

    ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response
    • 10
    • PDF
    Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways
    • 11
    • PDF
    Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
    • 104
    • PDF
    ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function
    • 11
    • PDF
    The p53-estrogen receptor loop in cancer.
    • 43
    Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.
    • 23
    Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis
    • 16
    • PDF
    ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway
    • 36
    • PDF
    ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling
    • 13
    • PDF
    Roles of Estrogens in Prostate Cancer Development via the Modulation of DNA-Repair System
    • 1
    • PDF

    References

    SHOWING 1-10 OF 46 REFERENCES
    p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
    • 535
    • PDF
    BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
    • 34
    • PDF
    Participation of p53 protein in the cellular response to DNA damage.
    • 3,841
    • PDF
    Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest
    • 483
    • PDF
    Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.
    • 273
    • Highly Influential
    Therapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function
    • 81
    • Highly Influential
    Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3
    • 215
    Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
    • 82
    Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
    • 186
    • PDF
    Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
    • 84
    • Highly Influential
    • PDF